68Ga-SNA018

N/A

Report date: 2025/11/17 17:57:29

Base Information

Drug Name68Ga-SNA018
Drug Alias Name68Ga-SNA01868Ga-SNA-01868Ga-ADAPT6
ClassificationBiologics > Protein drugs > Recombinant proteinRadiation-emitting products > Radioactive diagnostic agentRadiation-emitting products > Radionuclide Drug Conjugates +[4] 
Mechanisms of ActionReceptor protein-tyrosine kinase erbB-2 binders
TargetsReceptor protein-tyrosine kinase erbB-2
Therapy Area/IndicationsStomach NeoplasmsBreast Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesUppsala UniversityKth Royal Institute Of Technology
China Registration ClassN/A

Develop Information

Active CompaniesSmartnuclide Biopharma
Inactive CompaniesN/A
Active IndicationsStomach NeoplasmsBreast Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A